Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ascorbic acid + zinc (H & W Labs)
- Development stage
- Phase 3
- Lead developer
- H & W Labs
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
H-ZINC-C is an oral chewable tablet formulation combining ascorbic acid (Vitamin C) and zinc, developed and marketed by H & W Labs. It is utilized as a dietary supplement to support immune health, provide antioxidant protection, and address or prevent vitamin C and zinc deficiencies. Vitamin C is a water-soluble antioxidant that supports various cellular functions of both the innate and adaptive immune systems, while zinc is an essential mineral crucial for immune cell development and function. Together, the combination works synergistically to maintain overall health and vitality.
- Brand names
- H-ZINC-C
- Other names
- ascorbic acid + zincascorbic acid + zinc chewable tabletsvitamin C + zinc
Beyond the preview
Go deeper on ascorbic acid + zinc (H & W Labs).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ascorbic acid + zinc (H & W Labs).